Financials
Financial year 2025
PHARMACAM from Kraainem, company number BE0817415436, closed financial year 2025 with a result of € -27,913 after tax. For that financial year PHARMACAM recorded a gross margin of € 118,350 and equity of € 278,801. Compared with financial year 2024, the result moved from € 16,589 to € -27,913. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 278,801
▼ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -27,913
▼ still € 16,589 profit in 2024
Profit after tax over the fiscal year.
€ 54,344
▲ 45% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 208,950.
People and assets in 2025
€ 132,536
▲ 4% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,848
▼ 37% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 77,258
▲ 87% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 22,519
▲ 30% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 125,886 | € 158,757 | € 162,878 | € 118,350 | ▼ 27% |
| Profit after taxes | € 24,775 | € 20,421 | € 16,589 | € -27,913 | ▼ € 44,502 |
| Equity | € 269,704 | € 290,125 | € 306,714 | € 278,801 | ▼ 9% |
| Total debts | € 102,457 | € 153,785 | € 68,180 | € 131,824 | ▲ 93% |
| Cash | € 158,487 | € 174,962 | € 37,450 | € 54,344 | ▲ 45% |
| Land & buildings | € 69,106 | € 61,757 | € 67,708 | € 99,155 | ▲ 46% |
| Retained profit | € 199,853 | € 220,274 | € 236,864 | € 208,950 | ▼ 12% |
| Balance sheet total | € 372,161 | € 443,909 | € 374,894 | € 410,625 | ▲ 10% |
| Employees (FTE) | 1.5 | 1.6 | - | - |
Key figures of PHARMACAM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACAM?
What happened at PHARMACAM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 27,913 (▼ € 44,502 vs 2024). Source: NBB ↗
- New establishment in Kraainem. KBO
- Start of the company according to the CBE. KBO
In short
From € 24,775 profit in 2022 to € 27,913 loss in 2025.
Paid € 15,695 in corporate taxes since 2022.
Best year ever: 2022, with € 24,775 profit.
On average € 99,200 of value added per employee in 2023.
Management
Behind PHARMACAM is Andreas GHIJSELINGS. Andreas GHIJSELINGS is also behind PHARMALEC and PHARMACIE MATTERNE APOTHEEK.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Arthur Dezangrélaan 35
1950 Kraainem
Arthur Dezangrélaan 21
1950 Kraainem
Active since 1 September 2009
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0817.415.436
- VAT number
- BE 0817.415.436
- Registered office
- Arthur Dezangrélaan 35, 1950 Kraainem
- Names & denominations
- PHARMACAM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 July 2009
- Peppol
- Active · Active since 10 Jan 2025
- Activities · NACE
Detailhandel in farmaceutische producten